CHICAGO -- Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release. The study will ...

Enamine, a leading chemistry and R&D services company, today announced that it was a key synthetic chemistry contributor to a first-of-its-kind, open-science approach that led to the development of a ...

Kenilworth-based Merck is asking the U.S. Food and Drug Administration for emergency approval of a COVID-19 antiviral pill after trials for the drug showed promising results, the company announced Oct ...

SAN FRANCISCO -- A new type of COVID-19 therapy is showing promise as a new tool to hijack the virus and slow down variants. It's a new weapon that could be added to the arsenal against COVID-19.

Is it a cold or Covid? An expert M.D. breaks down the most common Covid symptoms to watch for right now—and how to stay ...

NEW YORK -- When Laura Martin tested positive for COVID-19 last month during an extended stay in California, she was prescribed Paxlovid, the highly touted antiviral drug created by Pfizer. Just one ...

As mask mandates are lifted, and mitigation measures are increasingly dropped across the nation, a stark reality continues to hinder the nation's return to a pre-pandemic sense of normality. Hundreds ...